Article Text
Therapeutics
Randomised controlled trial
The quadrivalent HPV vaccine is effective prophylaxis against HPV-related external genital lesions in young men
Statistics from Altmetric.com
Footnotes
-
Competing interests BD and AEG have received honoraria and research funding from CSL Biotherapies. BD has also received honoraria from Sanofi Pasteur MSD.